Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
Clinical trial NCT01670032 · COMPLETED
Trial details
- NCT number
- NCT01670032
- Sponsor
- NovaBay Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-08-01
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.